Pfizer Inc. (NYSE:PFE)

The financial trajectory from 2021 to 2025 reveals a significant shift from substantial value creation to a period of sustained economic value destruction. While the initial years showed strong performance, a sharp reversal occurred in 2023, and the organization has since struggled to return to a positive economic profit despite a recovery in operating income.

Net Operating Profit After Taxes (NOPAT)

NOPAT experienced a peak in 2022 at 31,018 million US$, followed by a severe contraction to a negative 1,277 million US$ in 2023. Although a recovery was observed in 2024 and 2025, with figures stabilizing near 7.2 billion US$, these levels remain significantly lower than the benchmarks established in 2021 and 2022.

Invested Capital and Cost of Capital

Invested capital expanded from 87,670 million US$ in 2021 to a peak of 154,882 million US$ in 2023, before moderating to 139,753 million US$ by 2025. The cost of capital remained relatively stable, fluctuating between a high of 10.04% in 2022 and a low of 8.66% in 2023. The substantial increase in the capital base effectively raised the minimum profit threshold required to generate positive economic value.

Economic Profit Trends

Economic profit transitioned from a peak of 19,897 million US$ in 2022 to a deficit of 14,690 million US$ in 2023. While the deficit narrowed in 2024 and 2025, economic profit remained negative at 4,567 million US$ and 5,159 million US$, respectively. This indicates that the operating returns are currently insufficient to cover the cost of the capital employed, resulting in a net destruction of economic value over the final three years of the period.

Net income attributable to Pfizer Inc. common shareholders and Net Operating Profit After Taxes (NOPAT) exhibited significant fluctuations between 2021 and 2025. While net income demonstrated an initial increase followed by a substantial decline, NOPAT mirrored this pattern with even more pronounced volatility, including a negative value in 2023.

Net Income Trend

Net income attributable to Pfizer Inc. common shareholders increased from US$21,979 million in 2021 to US$31,372 million in 2022, representing a substantial year-over-year growth. However, a dramatic decrease was observed in 2023, falling to US$2,119 million. A partial recovery occurred in 2024, with net income reaching US$8,031 million, followed by a slight decrease to US$7,771 million in 2025.

NOPAT Trend

NOPAT followed a similar trajectory to net income, increasing from US$18,394 million in 2021 to US$31,018 million in 2022. A significant shift occurred in 2023, with NOPAT becoming negative at US$-1,277 million. A recovery was then seen in 2024, rising to US$7,374 million, and continuing to US$7,193 million in 2025. The magnitude of the decline and subsequent recovery in NOPAT was greater than that observed in net income.

Relationship between Net Income and NOPAT

While both metrics generally moved in the same direction, the divergence in 2023 is noteworthy. The substantial negative NOPAT value suggests that operating profits, after accounting for taxes, were insufficient to cover the cost of capital employed during that year, despite a positive, albeit significantly reduced, net income. This indicates that factors beyond core operational profitability, such as financing or non-operating items, played a larger role in determining net income in 2023.

The period between 2024 and 2025 shows relative stabilization in both metrics, although NOPAT remains considerably lower than its peak in 2022. Further investigation would be required to understand the underlying drivers of these fluctuations and their implications for the company’s long-term financial performance.

The provision for taxes on income exhibits significant volatility over the observed period. Beginning at US$1,852 million in 2021, it increased substantially to US$3,328 million in 2022 before experiencing a dramatic shift to a benefit of negative US$1,115 million in 2023. This benefit continued, albeit at a smaller magnitude, in 2024 (-US$28 million) and 2025 (-US$267 million). In contrast, cash operating taxes demonstrate a more stable, though fluctuating, pattern.

Cash Operating Taxes Trend

Cash operating taxes increased from US$6,137 million in 2021 to US$7,967 million in 2022, representing a substantial rise. A subsequent decrease was noted in 2023, falling to US$2,113 million. Values then recovered somewhat in 2024 and 2025, reaching US$2,426 million and US$2,334 million respectively. While fluctuating, the values in 2024 and 2025 remain considerably below the 2021 and 2022 levels.

The divergence between the provision for taxes on income and cash operating taxes is noteworthy. The large benefit recorded in the provision for taxes in 2023, 2024, and 2025 suggests the utilization of tax loss carryforwards or other tax planning strategies, resulting in a reduced accounting expense despite continued cash outflows for taxes. The cash operating taxes, while decreasing from 2022 to 2023, remained positive throughout the period, indicating actual cash payments were made to tax authorities even when the accounting provision reflected a benefit.

Relationship between Provision and Cash Taxes

The difference between the provision for taxes on income and cash operating taxes widened considerably in 2023, 2024, and 2025. This indicates a growing deferral of taxable income or an increasing benefit from tax credits or loss carryforwards. The substantial difference highlights the impact of non-cash tax items on the reported income tax expense.

The observed trends suggest a complex tax position, potentially involving significant tax planning and the utilization of deferred tax assets. Further investigation into the specific drivers of the tax benefit and the nature of the deferred tax items would be beneficial for a complete understanding of the company’s tax strategy and its impact on financial performance.

The reported invested capital demonstrates a clear increasing trend over the observed period, followed by a stabilization and slight increase. A significant rise is noted between 2021 and 2023, while subsequent years show a more moderate pattern. This analysis details the observed movements in invested capital alongside its constituent components: total reported debt & leases and total shareholders’ equity.

Invested Capital Trend

Invested capital increased substantially from US$87,670 million in 2021 to US$154,882 million in 2023, representing a growth of approximately 76.8%. This growth slowed considerably in 2024, with invested capital decreasing to US$135,342 million. A modest increase to US$139,753 million was observed in 2025. The 2024 decrease suggests a potential shift in capital allocation strategy or a reduction in capital-intensive projects.

Debt & Leases

Total reported debt & leases decreased from US$41,395 million in 2021 to US$39,046 million in 2022. However, a substantial increase occurred in 2023, reaching US$75,041 million. This was followed by a decrease to US$66,993 million in 2024 and a slight increase to US$67,416 million in 2025. The 2023 surge in debt likely contributed significantly to the overall increase in invested capital during that year.

Shareholders’ Equity

Total shareholders’ equity increased from US$77,201 million in 2021 to US$95,661 million in 2022, indicating strong equity growth. A decrease was then observed in 2023, falling to US$89,014 million, and continued to decline in 2024 and 2025, reaching US$88,203 million and US$86,476 million respectively. This consistent decline in shareholders’ equity over the latter part of the period partially offset the impact of increased debt on invested capital.

The interplay between debt and equity significantly influences the overall invested capital. While debt increased substantially in 2023, the subsequent decrease in shareholders’ equity moderated the growth in invested capital in 2024 and 2025. The stabilization of invested capital in the later years suggests a balancing act between debt financing and equity returns.

The financial performance between 2021 and 2025 is characterized by a sharp transition from significant economic value creation to a period of sustained economic value destruction. A peak in profitability during 2022 was followed by a substantial decline in 2023, with subsequent years showing a stabilization of losses, although the company has not returned to positive economic profit.

Economic Profit

Economic profit exhibited significant volatility, rising from US$ 9,765 million in 2021 to a peak of US$ 19,897 million in 2022. A sharp reversal occurred in 2023, resulting in an economic loss of US$ 14,690 million. While losses narrowed to US$ 4,567 million in 2024, the figure widened slightly to US$ 5,159 million by 2025, indicating a persistent failure to generate returns exceeding the cost of capital in the latter part of the period.

Invested Capital

Invested capital followed a strong upward trajectory from 2021 to 2023, increasing from US$ 87,670 million to a peak of US$ 154,882 million. This growth suggests a period of aggressive capital deployment. A subsequent reduction to US$ 135,342 million in 2024 and a slight increase to US$ 139,753 million in 2025 indicate a phase of capital stabilization following the 2023 peak.

Economic Spread Ratio

The economic spread ratio reflects the volatility observed in economic profit, moving from 11.14% in 2021 to a peak of 17.97% in 2022. The ratio shifted to a negative 9.48% in 2023, signifying that the return on invested capital fell below the weighted average cost of capital. Although the ratio improved to -3.37% in 2024 and remained relatively stable at -3.69% in 2025, the negative spread confirms that the company continued to destroy economic value through 2025.

The financial trajectory between 2021 and 2025 is characterized by a period of significant expansion followed by a sharp contraction and a subsequent phase of marginal stabilization. There is a strong correlation between revenue volatility and the company's ability to generate economic value above its cost of capital.

Revenue Performance

Revenues experienced a peak in 2022, reaching 101,175 million USD. This was followed by a precipitous decline in 2023, where revenues fell to 59,553 million USD. For the periods ending December 31, 2024, and December 31, 2025, revenues remained relatively stagnant, fluctuating slightly between 62,579 million USD and 63,627 million USD.

Economic Profit Trends

Economic profit followed a similar pattern to revenues, increasing from 9,765 million USD in 2021 to a peak of 19,897 million USD in 2022. A critical reversal occurred in 2023, with economic profit falling to negative 14,690 million USD. Although the deficit narrowed to 4,567 million USD in 2024, it widened slightly to 5,159 million USD by the end of 2025, indicating a persistent failure to generate positive economic value.

Economic Profit Margin Analysis

The economic profit margin showed extreme volatility, rising from 11.89% in 2021 to 19.67% in 2022. The most significant deterioration occurred in 2023, with the margin plummeting to -24.67%. While there was a partial recovery to -7.18% in 2024, the margin shifted back to -8.24% in 2025. This trend suggests that while the intensity of value destruction has decreased since 2023, the company has not yet returned to a state of positive economic profitability.